
Sign up to save your podcasts
Or


Welcome to the most exasperated column yet in the ever-expanding Frontier Psychiatrists’ pharmacopeia of the gosh-darned. This is a daily health-related newsletter, and there is a lot behind the paywall (most writing past 5 weeks old)—consider subscribing and buying coffee makers I like from Amazon to support the work.
Other Include Risperidone, Depakote, Geodon, Ambien, Prozac, Xanax, Klonopin, Lurasidone, Olanzapine, Zulranolone, Benzos, Caffeine, Semeglutide, Lamotrigine, Cocaine, Xylazine, Lithium, dextromethorphan/bupropion and Adderall, etc.
TL;DR?
The world doesn't need Paxil.
Paroxetine is another SSRI. I have never prescribed it. If I had ever needed it to exist, I probably would have. Like Xanax, they got it over the line with panic disorder as an indication. This alone should have been a red flag.
It’s got a viciously short half-life. It’s got tons of awful adverse effects…
paroxetine was associated with a 620 percent increase in the rate of breast cancer in women who had taken it over a four-year period
Following this thread, which lands amid “eh-I-don’t-know-ville,” then takes you down a fiendishly complex rabbit hole of human biology. The genetics for why Paxil sucks are complex:
As many of these genes lie in the major histocompatibility complex (MHC), paroxetine may have downstream disruptive effects on synaptic pruning and over-editing of brain connections as well as polymorphic gene induction resulting in single nucleotide polymorphisms (SNPs) or even tri-nucleotide repeat polymorphisms (TNPs). This is speculation, but theoretically consistent with what is known about these phenomena.
This is complicated but probably not true of other oral antidepressants. I am a “smart doctor,” probably. Even I have precious little idea what the hell the authors are trying to say in the above paper other than “it’s complicated.”—like a Facebook relationship status in the late 2000s (h/t ) or an SBF explanation (h/t ) of the “where the money went.” (h/t ).
Paxil: It is to SSRIs what the FTT token was to cash money. It is conceptually related. BUT…didn't need to exist.
I was going to do a big long thing, like I do. I might still. In the case of Paxil, much like the brutal withdrawal phenomena, less is more. The following is the actual title of an academic review paper:
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
Paxil. I. Just. Can’t.
—Owen Muir, M.D.
By Owen Scott Muir, M.D.5
2929 ratings
Welcome to the most exasperated column yet in the ever-expanding Frontier Psychiatrists’ pharmacopeia of the gosh-darned. This is a daily health-related newsletter, and there is a lot behind the paywall (most writing past 5 weeks old)—consider subscribing and buying coffee makers I like from Amazon to support the work.
Other Include Risperidone, Depakote, Geodon, Ambien, Prozac, Xanax, Klonopin, Lurasidone, Olanzapine, Zulranolone, Benzos, Caffeine, Semeglutide, Lamotrigine, Cocaine, Xylazine, Lithium, dextromethorphan/bupropion and Adderall, etc.
TL;DR?
The world doesn't need Paxil.
Paroxetine is another SSRI. I have never prescribed it. If I had ever needed it to exist, I probably would have. Like Xanax, they got it over the line with panic disorder as an indication. This alone should have been a red flag.
It’s got a viciously short half-life. It’s got tons of awful adverse effects…
paroxetine was associated with a 620 percent increase in the rate of breast cancer in women who had taken it over a four-year period
Following this thread, which lands amid “eh-I-don’t-know-ville,” then takes you down a fiendishly complex rabbit hole of human biology. The genetics for why Paxil sucks are complex:
As many of these genes lie in the major histocompatibility complex (MHC), paroxetine may have downstream disruptive effects on synaptic pruning and over-editing of brain connections as well as polymorphic gene induction resulting in single nucleotide polymorphisms (SNPs) or even tri-nucleotide repeat polymorphisms (TNPs). This is speculation, but theoretically consistent with what is known about these phenomena.
This is complicated but probably not true of other oral antidepressants. I am a “smart doctor,” probably. Even I have precious little idea what the hell the authors are trying to say in the above paper other than “it’s complicated.”—like a Facebook relationship status in the late 2000s (h/t ) or an SBF explanation (h/t ) of the “where the money went.” (h/t ).
Paxil: It is to SSRIs what the FTT token was to cash money. It is conceptually related. BUT…didn't need to exist.
I was going to do a big long thing, like I do. I might still. In the case of Paxil, much like the brutal withdrawal phenomena, less is more. The following is the actual title of an academic review paper:
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
Paxil. I. Just. Can’t.
—Owen Muir, M.D.

37,390 Listeners

113,121 Listeners

296 Listeners

566 Listeners

454 Listeners

595 Listeners